ALEXANDRA ZHAKOV: Open Payments
NPI 1184220865 · WETHERSFIELD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$932 in 45 payments from 12 companies in 2025. Trend: 2023 $564 · 2024 $1,899 · 2025 $932
Food & beverage: $932
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 13 | $171 |
| Novartis Pharmaceuticals Corporation | 7 | $150 |
| Novo Nordisk Inc | 7 | $138 |
| E.R. Squibb & Sons, L.L.C. | 5 | $117 |
| Merck Sharp & Dohme LLC | 4 | $110 |
| Alnylam Pharmaceuticals Inc. | 2 | $68 |
| PFIZER INC. | 2 | $48 |
| Amgen Inc. | 1 | $31 |
| Actelion Pharmaceuticals US, Inc. | 1 | $30 |
| Abbott Laboratories | 1 | $24 |
Products named: JARDIANCE, LEQVIO, Wegovy, ELIQUIS, VERQUVO, CAMZYOS, Repatha, OPSUMIT.
Industry payments across CT — which companies pay providers there.
